NTRA
Price
$267.76
Change
-$1.90 (-0.70%)
Updated
Jul 31 closing price
Capitalization
38.35B
3 days until earnings call
Intraday BUY SELL Signals
PRCT
Price
$18.62
Change
+$0.62 (+3.44%)
Updated
Jul 31 closing price
Capitalization
1.06B
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NTRA vs PRCT

NTRA vs PRCT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NTRA vs. PRCT commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRA is a StrongBuy and PRCT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (NTRA: $267.76 vs. PRCT: $18.62)
Brand notoriety: NTRA and PRCT are both not notable
NTRA represents the Medical Specialties, while PRCT is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: NTRA: 66% vs. PRCT: 52%
Market capitalization -- NTRA: $38.35B vs. PRCT: $1.06B
NTRA [@Medical Specialties] is valued at $38.35B. PRCT’s [@Medical/Nursing Services] market capitalization is $1.06B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $182.9B to $0. The average market capitalization across the [@Medical Specialties] industry is $17.45B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRA’s FA Score shows that 1 FA rating(s) are green whilePRCT’s FA Score has 0 green FA rating(s).

  • NTRA’s FA Score: 1 green, 4 red.
  • PRCT’s FA Score: 0 green, 5 red.
According to our system of comparison, NTRA is a better buy in the long-term than PRCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRA’s TA Score shows that 4 TA indicator(s) are bullish while PRCT’s TA Score has 4 bullish TA indicator(s).

  • NTRA’s TA Score: 4 bullish, 4 bearish.
  • PRCT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PRCT is a better buy in the short-term than NTRA.

Price Growth

NTRA (@Medical Specialties) experienced а +2.20% price change this week, while PRCT (@Medical/Nursing Services) price change was +11.56% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.40%. For the same industry, the average monthly price growth was -3.39%, and the average quarterly price growth was +6.80%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.50%. For the same industry, the average monthly price growth was -7.49%, and the average quarterly price growth was -17.67%.

Reported Earning Dates

NTRA is expected to report earnings on Aug 06, 2026.

PRCT is expected to report earnings on Aug 04, 2026.

Industries' Descriptions

@Medical Specialties (+0.40% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (+2.50% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRA($38.3B) has a higher market cap than PRCT($1.06B). NTRA YTD gains are higher at: 16.880 vs. PRCT (-40.814). PRCT has higher annual earnings (EBITDA): -92.1M vs. NTRA (-227.7M). NTRA has more cash in the bank: 1.09B vs. PRCT (246M). PRCT has less debt than NTRA: PRCT (78M) vs NTRA (240M). NTRA has higher revenues than PRCT: NTRA (2.5B) vs PRCT (322M).
NTRAPRCTNTRA / PRCT
Capitalization38.3B1.06B3,613%
EBITDA-227.7M-92.1M247%
Gain YTD16.880-40.814-41%
P/E RatioN/AN/A-
Revenue2.5B322M777%
Total Cash1.09B246M442%
Total Debt240M78M308%
FUNDAMENTALS RATINGS
NTRA: Fundamental Ratings
NTRA
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTRAPRCT
RSI
ODDS (%)
Bearish Trend 4 days ago
72%
Bullish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
70%
Momentum
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
67%
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 7 days ago
77%
Bearish Trend 11 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
NTRA
Daily Signal:
Gain/Loss:
PRCT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KTB83.74-0.10
-0.12%
Kontoor Brands
CLIK1.42-0.01
-0.70%
Click Holdings Limited
CMG37.22-1.30
-3.37%
Chipotle Mexican Grill
RJET20.65-1.12
-5.14%
Republic Airways Holdings Inc.
OTLK0.98-0.06
-6.10%
Outlook Therapeutics

PRCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRCT has been loosely correlated with TNDM. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PRCT jumps, then TNDM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRCT
1D Price
Change %
PRCT100%
+3.44%
TNDM - PRCT
37%
Loosely correlated
+2.58%
TWST - PRCT
37%
Loosely correlated
+0.24%
RDNT - PRCT
35%
Loosely correlated
+1.74%
NTRA - PRCT
35%
Loosely correlated
-0.70%
IRMD - PRCT
34%
Loosely correlated
-4.57%
More